Loading...
Market
Which age group will have the highest vaccination rate with the updated COVID-19 vaccines in the U.S. by the end of 2024?
2
Resolution / Starting Odds
Children (6 months to 11 years) • 25%
Adolescents (12 to 17 years) • 25%
Adults (18 to 64 years) • 25%
Seniors (65 years and older) • 25%
CDC vaccination reports and public health data
Story
FDA Authorizes Updated COVID Vaccines Targeting KP.2 and JN.1 Strains
Aug 30, 2024, 07:06 PM
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for updated COVID-19 vaccines from Pfizer, Moderna, and Novavax. The Pfizer and Moderna vaccines target the KP.2 variant, while the Novavax vaccine targets the JN.1 strain and is protein-based. The Novavax vaccine is authorized for individuals aged 12 and older and is expected to be available in pharmacies and healthcare facilities across the United States soon. These vaccines aim to provide better protection against currently circulating variants and are recommended for everyone in the U.S. aged six months and older. The FDA's decision comes ahead of the fall season, with a push to increase vaccination rates to prevent serious consequences of COVID-19, including hospitalization and death. Novavax's vaccine offers a third fall option for COVID-19 immunization.
View original story
Similar markets
0-17 years • 25%
18-49 years • 25%
50-64 years • 25%
65+ years • 25%
0-5 years • 25%
6-10 years • 25%
11-15 years • 25%
16-20 years • 25%
2-12 years • 25%
13-24 years • 25%
25-35 years • 25%
36-49 years • 25%
2-12 years • 25%
13-24 years • 25%
25-34 years • 25%
35-49 years • 25%
65-74 • 25%
75-84 • 25%
85 and older • 25%
Immunocompromised individuals • 25%
2-12 years • 25%
13-24 years • 25%
25-49 years • 25%
50+ years • 25%
2-12 years • 25%
13-29 years • 25%
30-49 years • 25%
Equal uptake across all age groups • 25%
2-12 years • 25%
13-24 years • 25%
25-49 years • 25%
Evenly distributed • 25%
12-17 years • 25%
18-29 years • 25%
30-49 years • 25%
50+ years • 25%
2-18 years • 25%
19-29 years • 25%
30-49 years • 25%
All age groups equally • 25%
Under 5 years • 25%
5-11 years • 25%
12-17 years • 25%
No significant change • 25%
Under 5 years old • 25%
5-17 years old • 25%
18-49 years old • 25%
50 years old and above • 25%